FDA 510(k)

activL® 新一代仪器

K号: K231769 · 2023-07-13

决定日期2023-07-13

产品代码QLQ

咨询委员会OR 请注意，由于原文中未提供具体的医疗设备监管文本，以下是一个示例翻译，您可以根据实际文本进行调整： --- 产品名称：[产品名称] 公司名称：[公司名称] 根据FDA 510(k)预市场批准程序，[产品名称]已获得批准，用于[产品用途描述]。产品注册号：[注册号] PMA编号：[PMA编号] 临床试验编号（NCT）：[NCT编号] PubMed ID（PMID）：[PMID编号] 更多信息请访问以下链接： [URL] --- 请将上述示例中的[产品名称]、[公司名称]、[注册号]、[PMA编号]、[NCT编号]、[PMID编号]和[URL]替换为实际的文本内容。

决定实质等同

器械摘要

activL® Next Generation Instrumentation is the device name listed in this FDA 510(k) record. The listed applicant is Aesculap Implants Systems, LLC. It received FDA 510(k) clearance on 2023-07-13 under 510(k) number K231769. The device is classified under product code QLQ. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the activL® Next Generation Instrumentation?

activL® Next Generation Instrumentation is a medical device that received FDA 510(k) clearance on 2023-07-13. The listed applicant is Aesculap Implants Systems, LLC. The 510(k) number is K231769.

When did activL® Next Generation Instrumentation receive FDA 510(k) clearance?

activL® Next Generation Instrumentation received FDA 510(k) clearance on 2023-07-13, under 510(k) number K231769.

Who is the listed applicant for activL® Next Generation Instrumentation?

The FDA 510(k) record lists Aesculap Implants Systems, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for activL® Next Generation Instrumentation?

The FDA product code for activL® Next Generation Instrumentation is QLQ.

列明Aesculap Implants Systems, LLC为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K172235CoreHip® 系统

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。